期刊文献+

NAD^+和Nampt与SIRT1的研究进展 被引量:4

The Research Progression of NAD^+,Nampt and SIRT1
下载PDF
导出
摘要 热量限制可以引起细胞、生物体寿命延长和降低衰老相关疾病的发生。沉默信息调节因子2在酵母和果蝇中已被证实是热量限制引发长寿效果的关键,在哺乳类动物中的名字是沉默信息调节因子1(SIRT1)。最近,SIRT1的激活物烟酰胺腺嘌呤二核苷酸(NAD+)成了研究中心,因为它很可能是连接细胞及生物体的能量代谢和热量限制导致延缓衰老中枢。与NAD+相关的还有NAD+的限速酶尼克酰胺磷酸核糖转移酶(Nampt)和细胞能量调节因子腺苷酸活化蛋白激酶及NAD+下游因子Sir2-相关酶类(sirtuins)家族成员。它们之间的关系研究的最终结果就很可能解释在哺乳类动物中热量限制的奥秘,从而为今后以此为靶点的药物开发奠定良好的基础。 Calorie restriction(CR) can make organism and cell have a long life and decrease the diseases which is relate to aging. Sir2,which was proved to play a key role in yeast and fly's CR,is named SIRT1 in mammalian. Recent research have put NAD^+ , the activator of SIRT1, in center, because it may the connection of cell and organism's energy metabolize and the centre of aging, Nampt, NAD^+ rate-limiting enzyme, cells' energy regular factor AMPK and NAD ^+ downstream family Sirtuins, was also related to the NAD^+ . The final conclusion of their interaction may explain the secret of CR in mammalian.
出处 《医学综述》 2010年第7期968-971,共4页 Medical Recapitulate
基金 国家自然科学基金青年基金(30800580) 北京市科技新星计划(2007B014) 北京市自然科学基金(5093025)
  • 相关文献

参考文献22

  • 1Koubova J, Guarente L. How does calorie restriction work[J]. Genes Dev,2003,17 (3) :313-321.
  • 2Revollo JR, Korner A, Mills KF, et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme[ J]. Cell Metab,2007,6 (5) :341-343.
  • 3Revollo JR,Grimm AA,Imai S,et al. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals[ J ]. Curr Opin Gastroentero1,2007,23 ( 2 ) : 164-170.
  • 4hnai S. The NAD world:a new systemic regulatory network for metabolism and aging-SIRTl, systemic NAD biosynthesis, and their importance [ J ]. Cell Biochem Biophys ,2009,53 (2) :65-74.
  • 5Magni G,Amici A, Emanuelli M, et al.Enzymology of NAD^+ homeostasis in man[J]. Cell Mol Life Sci,2004,61 ( 1 ) :19-34.
  • 6Revollo JR, Grimm AA, Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyhransferase regulates Sir2 activity in mammalian cells [ J ]. J Biol Chem, 2004,279 ( 49 ) : 50754-50763.
  • 7Grubisha O, Smith BC, Denu JM. Small molecule regulation of Sir2 protein deacetylases [ J ]. FEBS J,2005,272 ( 18 ) : 4607 -4616.
  • 8Vousden KH. p53 : death star[ J ]. Cell ,2000,103 ( 5 ) :691-694.
  • 9van der Veer E,Ho C,O'Neil G,et al. Extension of human cell lifespan by nicotinamide phosphoribosyltransferase [ J ]. J Biol Chem,2007,282( 15 ) : 10841-10845.
  • 10Mostoslavsky R, Chua KF, Lombard DB, et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6 [ J]. Cell .2006.124(2 ) :315-329.

同被引文献106

  • 1王峰,张纬萍.尼克酰胺磷酸核糖转移酶与衰老及衰老相关疾病研究进展[J].浙江大学学报(医学版),2011,40(6):680-684. 被引量:3
  • 2朱丽,叶红.Nampt在卵巢癌中的研究进展[J].现代生物医学进展,2011,11(S2):5197-5200. 被引量:2
  • 3McGettrick AF, O'Neill LA. How metabolism generates signals during innate immunity and inflammation. J Biol Chem, 2013, 288(32): 22893-8.
  • 4O'Neill LA, Hardie DG. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature, 2013, 493(7432): 346-55.
  • 5Hardie DG, Ross FA, Hawley SA. AMP-activated protein kinase: a target for drugs both ancient and modern. Chem Biol, 2012, 19(10): 1222-36.
  • 6Carling D, Thornton C, Woods A, et al. AMP-activated protein kinase: new regulation, new roles? Biochem J, 2012, 445(1): 11-27.
  • 7Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol, 2012, 13(4): 251-62.
  • 8Yang Z, Kahn BB, Shi H, et al. Macrophage α1 AMPactivated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J Biol Chem, 2010, 285(25): 19051-9.
  • 9Giri S, Nath N, Smith B, et al. 5-aminoimidazole-4- carboxamide-1-β4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMPactivated protein kinase. J Neurosci, 2004, 24(2): 479-87.
  • 10Meares GP, Qin H, Liu Y, et al. AMP-activated protein kinase restricts IFN-γ signaling. J Immunol, 2013, 190(1): 372-80.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部